Kevin J. Scanlon, Ph.D.
Founder and CEO

[Arrow] We are at the threshold of a medical revolution for the diagnosis and treatment of human disease. Our Mission at International BioScience is to integrate the Creative Knowledge of Science with the Core Disciplines of Business Development Strategies

[Arrow] Dr. Kevin J. Scanlon's background includes: academic medicine, senior management in the pharmaceutical industry, CEO of four start-up biotechnology companies and an angel investor. Some examples of his experiences includes the following:

  • Dr. Kevin Scanlon has been a CEO and Chairman of four life science technology companies. Melanoma Diagnostics, has a molecular assay that can discriminate moles from melanoma, was sold to Myriad Genetics, Inc. (Salt Lake City, UT).
  • Dr. Kevin Scanlon has been in the investment community for the past 10 years. Currently, he is the Emeritus Chairman of Pasadena Angels Investment Group. This organization support entrepreneurs with seed round investments for their novel technology. (Investment Community) Read his Entrepreneurial Economy article from the Technolink Association Newsletter in Adobe PDF Format.
  • He is a UCLA School of Management faculty advisor for FEMBA graduate business students involved in the Global Access Program. ( (Teaching)
  • Dr. Scanlon has worked with entrepreneurs, the investment community and international governments in Ireland, New Zealand and China to create an innovative culture around the intellectual property from their academic institutions. (Events)
  • As a Pharmaceutical Industry-Vice President at Berlex-Schering AG (Berlin, Germany), he was responsible for the company's international cancer program in the US, Europe and Asia. (Industry)
  • Dr. Scanlon received his Ph.D. degree from the University of London in Molecular Biology and trained in Cancer Research at Yale Medical School. He was a Leukemia Society Scholar, awarded the Paul Martini Medical Research Prize in Cancer (Germany), was the past President of the International Society of Cell and Cancer Gene Therapy (England), was a participant at 400th Anniversary of Uppsala University (Sweden), is an advisor for the National Institute for Cellular Biotechnology (Ireland), Co-Founder of Nature’s "Cancer Gene Therapy", co-authored over 137 original scientific articles, edited nine medical books and has seven issued patents. (Science)
BiographyEventsArticlesAngel InvestingBoardsConsultingIndustry
TeachingScienceBiotech CenterPhotosWebcastsLinksContact Us

You are visitor number 181,078 to the KJScanlon website.

Baywalk MarketingTop of Page